Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 24 Suppl 2, 161-71

Modulating Alzheimer's Disease Through Caffeine: A Putative Link to Epigenetics

Affiliations
Review

Modulating Alzheimer's Disease Through Caffeine: A Putative Link to Epigenetics

Sueli Marques et al. J Alzheimers Dis.

Abstract

Aging is the best-known risk factor for many disorders, including neurodegenerative diseases such as Alzheimer's disease (AD). The effect of epigenetic modulation of gene expression on normal aging and in pathological conditions is still unclear, but it is likely it may explain some of the complexity that is characteristic of these processes. Caffeine is a widely consumed psychoactive drug, which is emerging as a protective agent against AD progression and in aging associated deficits. This occurs mainly through the blockade of adenosine A2A receptors, whose expression and function become aberrant throughout aging and in age-related pathologies. Here, we discuss the data supporting the effects of caffeine in AD, focusing on adenosine A2A receptors and epigenetic modulation of gene expression. In addition, we speculate on the potential of caffeine as an epigenetic modulator and the consequences it might have for preventive and therapeutic applications of caffeine in AD.

Similar articles

See all similar articles

Cited by 5 PubMed Central articles

Publication types

MeSH terms

LinkOut - more resources

Feedback